Palatin Technologies Inc. (PTN)

[Theo]

From the transcript:

"We're also advancing bremelanotide along certain pre-launch and commercial readiness tracks. These actions include pricing, insurance reimbursements, packaging and trade name activities. In light of the above events and significant progress of the bremelanotide Phase 3 clinical trials, we have received significant enhanced interest from potential licensing partners We believe that there is a substantial US and global market for bremelanotide and we continue to make progress with our licensing activities."

Regarding licensing. Notice the bold:

Steve Wills

"This is Steve, I’ll take this one, the way we have approached the potential collaboration process it’s been somewhat ongoing. We have discussions on a contemporaneous basis and we’re prepared to depending on several factors to move the program regarding the collaboration very quickly if we think that makes sense. So there is no question the data that comes out late third quarter is going to be the primary drier of those collaboration chats but we are not going to be starting the process at an early we're at definitely an advanced stages of discussions and due diligence with a number of potential collaboration partners."

Gives me the impression that there might be some sort of handshake type of agreement already in place with someone if phase III results are positive especially if the results are overwhelming even prior to completion of phase III... i.e., "we’re prepared... to move the program regarding the collaboration very quickly..."